Brain Tumor Drugs Market to Reach US$ 5.41 Billion by 2033 Driven by Oncology Innovation
The increasing prevalence of brain tumors, growing investments in cancer research, and rapid advancements in oncology therapies are driving the expansion of the global Brain Tumor Drugs Market. Pharmaceutical companies are focusing on developing innovative treatment approaches that improve patient …